We want to talk to caregivers about their experiences talking to doctors about their child's behaviours. A lot of children with neurodevelopmental disorders, like autism, have unsafe behaviours. They may hurt themselves, be aggressive to others, or do things that put them in danger like running away. A doctor can help these children, but sometimes the doctors want or need to help with other problems before they help with these behaviours. If you have talked to a doctor about your child's behaviours, or have tried to talk about these behaviours with a doctor, we want to hear from you. We are talking with caregivers about how they talk to doctors about these behaviours, if there are any challenges, and what has helped. This will help us understand how doctors can better respond to these behaviours and support families.

Egg Freezing is an increasingly common fertility treatment, and IVF is currently responsible for approximately 2% of all live births in Canada. The IVF and egg-freezing procedures involve administering high doses of hormones, which have been associated with changes to body composition. These changes have the potential to impact body image, however, the relationship between these treatments and individuals' body image remains poorly understood. This study aims to address this knowledge gap and provide insights that could improve patient care and support during fertility treatment and care.

This study is about understanding why some Albertans use an online tool called MyHealth Alberta to see and manage their health information while others do not. MyHealth Alberta lets people look at things like their lab test results, medications, and immunizations on their computer or phone. The study wants to find out what makes it hard for people to use this tool and what could be done to help more people use it easily. The goal is to listen to Albertans from different backgrounds and places to learn about their experiences with MyHealth Alberta. The study will collect ideas on how the tool could be better and more accessible for everyone. Using a group discussion method called the World Café, the study will create a friendly space where people can share their thoughts and work together.

Over 30% of people with epilepsy also struggle with a mental health disorder, the most common one being depression. Depression can make epilepsy symptoms more severe and harder to manage, making it difficult for people with epilepsy and depression to adhere to their treatment plans. This can lead to a lower quality of life for people living with both conditions. This study aims to identify the information and tools people with epilepsy need to help manage their depression. To support this process, our team is conducting a questionnaire, focus group and World Café interviews to better understand the information needs of people living with epilepsy and depression, as well as the tools that may help them manage their condition. This study seeks to address the following research questions: 1. What are the information needs of people with epilepsy who are affected by depression? 2. What tools are available to facilitate the management of depression in epilepsy?

Dr. Jason Weatherald and other researchers from the Department of Medicine at the University of Calgary are conducting a research study. Long COVID Syndrome (Long COVID) is defined by persistent symptoms (including breathlessness, chest pain and fatigue) after COVID-19 illness that continue for more than 12 weeks and cannot be explained by another diagnosis. The goal of this project is to explore the underlying cause of the ongoing symptoms of patients suffering from Long COVID. You are invited to participate in this research study, if you have ongoing symptoms after COVID-19, would like to volunteer as a person who has recovered from COVID-19 or you have pulmonary vascular disease of another type. Your participation in this research study is voluntary. Taking part in this study will require you to complete some tests used to find out the cause of unexplained shortness of breath in patients including a Chest x-ray, Pulmonary function tests, Cardiopulmonary exercise test (CPET) and Right Heart Catheterization (RHC) with exercise. If you are interested in the study please call at 403-210-7861 to get more information about the study.

While we know that yoga may improve IBS symptoms, we do not know exactly why. During this study, participants will undergo an MRI scan and blood draw, then participate in 9 week of free yoga practice developed to improve IBS symptoms. By participating in this study, you will help researchers better understand how lifestyle changes can improve IBS symptoms.

Many children and teens with mental health conditions like depression, anxiety, or OCD are given medications, either on their own or along with therapy. But up to half of these young people do not get better from the medication or may have unwanted side effects. Today, treatment for children often works through trial and error, which can be stressful for both youth and their families. Pharmacogenetic (PGx) testing could help avoid this. PGx testing is a type of genetic test that looks at a person’s genes to see how quickly their body breaks down certain medications. This information can help doctors choose medication and dosage for each child. Our goal is to create and test a strategy for adding PGx testing into youth mental health care in Alberta.

This randomized controlled trial is to see the effects of a drug called sertraline on anxiety in children and adolescents with Neurodevelopmental Conditions / Disorders (NDDs): including Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), Tic Disorders, Fragile X syndrome, Tuberous Sclerosis, 22q11 deletions. Though Sertraline has been studied in children, and adolescents with obsessive compulsive disorder (OCD) and with major depression, research is needed to confirm whether sertraline can help improve anxiety in children and youth with NDDs.

Patients who present to the Foothills hospital with acute stroke symptoms receive a CT scan of their brain. If there is a blockage in one of the arteries, supplying blood to the brain and there is no hemorrhage, and if they are eligible, they receive standard stroke treatment, which is administration of a clot dissolving agent and repeat imaging of the brain to check if the clot is dissolved. Depending on the location of the clot, sometimes thrombectomy is also performed. During thrombectomy, the doctor makes a small cut and places a thin hollow tube (catheter) into a blood vessel in the patient's groin. The tube is advanced into the blood vessels in the neck and head. Dye is be injected into the tube several times and x-rays are taken to help view the blockage. The doctor try to remove the clot by putting a Health Canada approved device (eg. a stent retriever or other device) into the artery with the clot and removing the clot into the tube and pulling it out of the patient's body. Thrombectomy is a standard of care to the patients who have occlusion in the large vessel. However, we do not have data to help decide the doctors, if the same technique will work for certain medium vessel blockage or not. Currently there are smaller devices available, which are useful in accessing the medium size vessels and current study will gather information as to whether the thrombectomy treatment results in better outcome for the patients or not.

We are investigating the effectiveness of video-based apps in healthcare settings. We are looking for people to test these apps! Participants will receive $60 in Everything Card gift cards in appreciation of their time.